The OPTIMAL TDM Study: Determining Optimal Beta-lactam Plasma Concentrations Through Therapeutic Drug Monitoring

Clinical trial NCT03790631 · COMPLETED

Trial details

NCT number: NCT03790631
Sponsor: University of Geneva, Switzerland
Status: COMPLETED
Study type: OBSERVATIONAL

Beta-lactam Antibiotics Therapeutic Drug Monitoring Toxicity Efficacy Imipenem Meropenem Piperacillin Flucloxacillin Amoxicillin Ceftazidime Cefepime

Start date: 2019-01-14
Primary completion: 2023-12-31
Enrollment: 771

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.